"The FDA has granted psilocybin breakthrough therapy designation for the treatment of major depressive disorder and treatment resistant depression.
The passage of Measure 109 in November 2020 gives Oregon two years to create a licensing and regulatory system for legal use of psilocybin. After decades of banned research from the "War on Drugs", there are now numerous studies exploring psilocybin for depression, end-of-life anxiety, substance abuse, smoking cessation, and more.
CPM has submitted an application for a Psilocybin Service Center license and will update this site when we are ready to serve clients. Thank you for your patience!"